University of Manchester Launches MPS II Gene Therapy Trial, Picking Up Where AVROBIO Left Off
November 5th 2023UoM was previously collaborating on the development of AVR-RD-05 with AVROBIO, but regained the license to the HSC gene therapy following the company’s cessation of development on all programs.
Autologous Natural Killer Cell Therapy Produces Positive Results in 3 Sarcoma Case Studies
October 14th 2023Nadezhda Omelchenko, MD, a research associate at Cancer Center of Southern California in Santa Monica, discussed findings from patients treated with a combination therapy that included NK cell therapy SNK01.